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INTRAVASCULAR DEVICE FOR AXIALLY 
STRETCHING BLOOD VESSELS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
2 
Graft Surgery, American College of Cardiology/ American 
Heart Association, J. Am. Coll. Cardiol., 34(4):1262-347 
(1999)). 
Development of a longer lasting small-diameter vascular 
graft is the subject of much academic and industrial 
research. One current approach is to combine cell culture 
and biomaterials technologies to make a living, "tissue 
engineered" graft. This effort, however, is hindered by the 
This is a continuation of U.S. patent application No. 
10/093,715, filed Mar. 7, 2002, now U.S. Pat. No. 7,018,402 
which claims benefit under 35 U.S.C. § 119 of U.S. Provi-
sional Application No. 60/274,703, filed Mar. 9, 2001. These 
applications are incorporated herein by reference 
BACKGROUND OF THE INVENTION 
10 requirements of a successful graft. The graft should be 
self-repairing, non-immunogenic, non-toxic, and non-
thrombogenic; should have a compliance comparable to the 
artery being repaired; should be easily sutured by a surgeon; 
and should not require any special techniques or handling 
The present invention is generally in the area of methods 
and devices for producing vascular tissue grafts from living 
vascular tissue, and particularly for making autologous 
grafts. 
15 procedures. Grafts having these characteristics are difficult 
to achieve. Despite the substantial effort to date and the 
potential for significant financial reward, academic and 
industrial investigators have failed to produce graft materials 
Vascular grafts are commonly used by surgeons to bypass 
obstructions to blood flow caused by the presence of ath- 20 
erosclerotic plaques. Vascular grafts also are used in other 
applications such as providing arterial-venous shunts in 
dialysis patients, vascular repair or replacement and treating 
aneurysms. Grafts for bypass are often, but not exclusively, 
used in the coronary arteries, the arteries that supply blood 25 
to the heart. 
The materials used to construct a vascular graft usually 
are either synthetic or of biological origin, but combinations 
that have demonstrated efficacy in human testing. 
Efforts to avoid or minimize the need for vascular grafts 
for repair of otherwise healthy vascular tissue have been 
described. For example, Ruiz-Razura et al., J. Reconstruc-
tive Microsurgery, 10(6):367-73 (1994) and Stark et al., 
Plastic & Reconstructive Surgery, 80(4):570-78 (1987) dis-
close the use of a round microvascular tissue expander for 
acute arterial elongation to examine the effects on the tissue 
of such acute hyperextension. The expander is a silicone 
balloon that is placed under the vessel to be elongated. The of synthetic and biological materials are under development. 
The most widely used biological vascular grafts are autolo-
gous saphenous vein or mammary artery. Some common 
synthetic grafts are made of polytetrafluoroethylene (PTFE) 
(e.g., GORTEX™) or polyester (e.g., DACROWM). Autolo-
gous grafts have generally been used more successfully than 
synthetic grafts. Autologous grafts remain patent (func-
tional) much longer than synthetic grafts, and saphenous 
veins often fail in less than five years. The short lifetime of 
synthetic grafts is especially evident with small diameter 
(less than 7 mm diameter) grafts, as most small diameter 
synthetic grafts occlude within one to two years or less. 
30 balloon is filled with saline over a very short period, causing 
acute stretching and elongation of the vessel. The method is 
purported to be effective for closure of arterial defects up to 
30 mm without the need for a vein graft. These techniques 
are appropriate for trauma, but are not used for restoring 
35 blood flow in vessels that are occluded, for example by 
disease, which are treated by surgically bypassing the 
obstruction with a graft. The disclosed methods and devices 
fail to provide an autologous graft or versatile substitute. 
Moreover, the acute stretching may damage the vessel. 
40 
Small diameter vascular grafts are particularly used in 
coronary artery bypass surgery. Internal mammary artery 
(IMA) is the autologous graft of choice, because it typically 
has a longer life than venous grafts (95% patent at five years 
versus 85% patent at two years). Mammary arterial tissue, 45 
however, is difficult to harvest, is typically not available in 
lengths sufficient for multiple bypasses, and its removal can 
result in problems such as problematic wound healing. 
Moreover, obtaining sufficient venous tissue for repairing an 
occluded artery can be problematic in patients with venous 50 
conditions such as varicose veins and especially in second or 
third surgeries in the same patient. Literature also suggests 
that IMA used in bypass procedures either fails soon after 
transplantation or remains patent indefinitely. See, e.g., 
Bergsma, et al., Circulation 97(24):2402-05 (1998); Cooley, 55 
Circulation 97(24):2384-85 (1998). 
Other arteries such as the gastroepipolic, gastric, radial, 
and splenic also are used in coronary bypass procedures. In 
some cases, autologous or homologous saphenous vein 
preserved by freezing or other processes is used. A recent 60 
American Heart Association/American College of Cardiol-
ogy consensus document strongly recommends a move to 
total arterial revascularization (Eagle, et al. "ACC/AHA 
Guidelines for coronary artery bypass graft surgery: A report 
of the American College of Cardiology/ American Heart 65 
Association Task Force on Practice Guidelines", Committee 
to Revise the 1991 Guidelines for Coronary Artery Bypass 
It has been demonstrated, however, that axial stretching 
can increase smooth muscle cell proliferation in an intact 
blood vessel, thereby substantially enhancing blood vessel 
growth. See Conklin, "Viability of Porcine Common Carotid 
Arteries in a Novel Organ Culture System" MS Thesis, 
Georgia Institute of Technology, 1997); Han, et al., "Axial 
Stretch Increases Cell Proliferation in Arteries in Organ 
Culture", Advances in Bioengineering ASME, BED 48:63-
64 (2000). 
PCT WO 99/60952 to Georgia Tech Research Corpora-
tion and U.S. Pat. No. 6,322,553 to Vito describe devices 
and methods for producing axial growth by mechanically 
stimulating a blood vessel using axial distention. These 
devices anchor to exterior surfaces of the blood vessels, and 
consequently their use in vivo is necessarily invasive, at 
least requiring endoscopic surgery. The size of the devices 
also may limit the sites that are suitable for implantation. It 
would be advantageous to develop devices and methods that 
are less invasive and more easily installed and used in vivo. 
It would also be tremendously beneficial to the patient to be 
able to eliminate the need for surgery before removal of the 
grown blood vessel for use as an autologous graft. It would 
be desirable to provide minimally- or non-invasive devices 
and methods for stretching and growing blood vessels in 
vivo. It also would be desirable to provide simple devices 
and methods for creating natural blood vessel suitable for 
grafting, and for making an autologous blood vessel graft 
with fewer surgeries. 
US 7,300,455 B2 
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SUMMARY OF THE INVENTION 
Intravascular devices and methods are provided for form-
ing a vascular graft by axially distending a blood vessel to 
stimulate vessel growth. These devices advantageously can 
be implanted via a catheter, thereby eliminating the need for 
a more invasive implantation procedure when the stretching 
is to be done in vivo. Where the vessel donor is the recipient 
of the graft, a totally autologous, living vascular graft is 
provided. 
The device for axially distending a blood vessel to induce 
growth of the vessel includes an intravascular stretching 
mechanism attachable directly to an interior lumen portion 
of the blood vessel, and a means for operating the stretching 
mechanism to cause the vessel to distend axially. In a 
preferred embodiment, the intravascular stretching mecha-
nism is composed of an anchoring wire and a stretching 
wire, wherein the distal end portions of these wires are 
separately anchorable to the interior lumen portion at posi-
tions axially remote from one another. The device may 
further include a catheter having at least two lumens that are 
suitable for delivering the stretching wire and the anchor 
wire into the interior lumen portion of the blood vessel. The 
catheter and wires can be provided as a kit or an assembled 
device. 
The distal end portion of the anchoring wire, the distal end 
portion of the stretching wire, or both, can include or be 
formed of a shape memory material. Preferably, the shape 
memory material comprises nickel-titanium or a shape 
memory polymer. In operation of such an embodiment, the 
shape memory material changes shape in response to an 
effective temperature change, such as the temperature 
increase experienced following insertion of the material into 
4 
In any of these embodiments, the intravascular stretching 
mechanism, or a portion thereof, can include a therapeutic or 
prophylactic agent, such as a growth-stimulating agent, 
which can be released in an effective amount to enhance 
growth of the blood vessel. Another example is an anti-
thrombotic agent to minimize the risk of a blood clot during 
the stretching process. The therapeutic or prophylactic agent 
can be impregnated in or coated onto the device compo-
nents, and/or added and released through a lumen in the 
10 catheter that delivers the device to its intravascular position. 
Methods are provided for distending a blood vessel of a 
human or animal to induce blood vessel growth. The steps 
include (i) inserting into an interior lumen portion of a blood 
vessel the stretching mechanism of the devices described 
15 herein; (ii) anchoring the stretching mechanism to the inte-
rior lumen portion at at least two positions which are axially 
remote from one another; and (iii) operating the stretching 
mechanism to axially stretch the blood vessel between said 
at least two positions over a period of time effective to 
20 induce axial growth of the blood vessel. This operation step 
could be active (e.g., applying an external force to the 
mechanism or a component thereof) or passive (e.g., simply 
releasing an elastic force, such as a spring). The stretching 
can be performed in vivo or in vitro in a medium for cell 
25 growth. 
Methods are also provided for forming a vascular graft for 
a human patient in need thereof. The methods include the 
steps of distending a donor blood vessel by use of one of the 
intravascular stretching devices and methods described 
30 herein, and then excising a portion of the distended donor 
vessel, that portion thereby providing a vascular graft. While 
a variety of blood vessel types could be stretched as 
described herein, the blood vessel preferably is selected 
from an internal manmiary artery, a femoral artery, a gas-a live mammalian body. The shape change, for example, can 
cause the distal end portion of the stretching wire to change 
from a substantially straight form into a spiral configuration 
which frictionally engages a first position in the interior 
lumen portion of the blood vessel and then can cause the 
distal end portion of the anchoring wire to change from a 
substantially straight form into a spiral configuration which 40 
engages a second position in the interior lumen portion of 
the blood vessel. Stretching forces can then be applied to the 
wire(s) to push/pull the distal portions away from each other. 
35 troepipolic artery, a gastric artery, a radial artery, and a 
splenic artery, when stretching the vessel to form a vascular 
graft. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a perspective view of the parts of one embodi-
ment of the intravascular device, which includes a multi-
lumen catheter, an anchor wire, and stretching wire. 
In one variation, the stretching wire can further include an 45 
intermediary portion which changes shape, for example by 
use of a shape memory material, from a substantially straight 
form into a helical configuration which functions as a 
compression spring to impart the stretching forces. 
The means for operating the stretching mechanism can 50 
include a prime mover that is mechanically, electromechani-
cally, or hydraulically driven. This operating means can 
cause the axial stretching force to be applied to the vessel in 
a continuous, intermittent, or cyclical manner, and applied 
rectilinearly, curvilinearly, or in a combination thereof. The 55 
device can also include a controller for controlling the 
means for operating the stretching mechanism. 
FIG. 2 is a perspective view of a wire having a distal end 
portion comprising a shape memory material in a straight 
configuration (FIG. 2A) and in a spiral configuration (FIG. 
2B). 
FIGS. 3A-E are partial cross-sectional views of a blood 
vessel in which one embodiment of the intravascular device 
is being deployed and operated to stretch the blood vessel, 
using external force to push an anchored stretching wire 
away from an anchor wire. 
FIG. 4 is a perspective view of a wire having a distal end 
portion comprising a shape memory material in a straight 
configuration (FIG. 4A) and in a complex configuration 
having a spiral end and a compression spring (FIG. 4B). 
In another preferred embodiment, the intravascular 
stretching mechanism comprises a first stent, a second stent, 
and a compression spring operably connected to the first 
stent and the second stent, wherein the first and second stents 
are separately anchorable to the interior lumen portion at 
positions axially remote from one another. In this embodi-
ment, the first stent, the second stent, the compression 
spring, or a combination thereof, can include a shape 
memory material, such as a nickel-titanium alloy or a shape 
memory polymer. 
FIGS. SA-E are partial cross-sectional views of a blood 
vessel in which a second embodiment of the intravascular 
60 device is being deployed and operated to stretch the blood 
vessel, using an integral compression spring to push an 
anchored stretching wire away from an anchor wire. 
FIG. 6 is a side view of one embodiment of the intravas-
cular stretching device, which includes two stents and an 
65 integral compression spring, which comprises a shape 
memory material, shown in a compressed configuration 
(FIG. 6A) and in an expanded configuration (FIG. 6B). 
US 7,300,455 B2 
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FIG. 7 is a side view of a stent and its integral compres-
sion spring, which form part of one embodiment of the 
intravascular stretching device. 
FIG. Sis a side or plan view of a one embodiment of the 
intravascular stretching device, which includes two stents 
and an integral compression spring shown in a compressed 
configuration (FIG. SA) and in a curvilinear expanded 
configuration (FIG. SB). 
DETAILED DESCRIPTION OF THE 
INVENTION 
6 
displace the stents away from each other and stretch the 
vessel. As used herein, the term "stent" refers to an elastic, 
expandable, generally cylindrical anchor capable of engag-
ing a blood vessel wall and resisting axial forces; it may or 
may not be structurally like a conventional stent, which 
primarily serves to resist radial forces. 
It is possible that components of these two different 
designs can be combined, for example, using a combination 
of stents and wires to perform the stretching process. It is 
10 also envisioned that these anchoring elements can take the 
form of other suitable structures now known or later devel-
oped, as the choice of anchoring elements generally can be 
considered a matter of design choice. It is known that smooth muscle cells, which dominate the 
media, the major load bearing layer of the arterial wall, 
proliferate and increase their production of extracellular 15 
matrix in response to mechanical stimulation. It was dis-
covered that this knowledge could be advantageously 
applied to create an autologous graft of appropriate diameter 
for coronary bypass or other vascular graft application using 
A. Design Utilizing Anchored Wires 
In some embodiments, the device employs two wires 
anchored within the blood vessel to be stretched. Examples 
of these are shown in FIGS. 1-5 and described below. 
The Device and Components Thereof 
As shown in FIG. 1, a kit 10 includes a multi-lumen 
catheter 12 and at least two wires: a stretching wire 14a and 
an anchor wire 14b. The catheter 12 has proximal end 16 and 
opposed distal end lS, and has four lumens, 17a, 17b, 17c, 
and 17d. 
an intravascular distension device to stimulate angiogenesis. 20 
The distension device secures the donor blood vessel at 
different points within the vessel and then distends or 
stretches the vessel between those points to form an elon-
gated portion. The elongated portion can then be excised for 
use as a vascular graft. The devices and methods described 25 
herein can used to make allogeneic and xenogeneic vascular 
grafts, as well as the more preferred autogeneic vascular 
grafts. 
The catheter and wires can be provided as a kit or an 
assembled device. The catheter can be a standard, commer-
cially available catheter. The catheter preferably has at least 
two lumens, one for each of the two wires. Additional 
lumens can be included for cold saline or other purposes. 
Selection of the appropriate diameter and length for the 
The Devices and Methods of Operation 
The device includes a stretching mechanism that can be 
attached to and within a donor blood vessel, and a means for 
operating the stretching mechanism to cause the vessel to 
distend (i.e., extend), and an optional controller for control-
ling the operating means. At least two anchoring points are 
needed to stretch the blood vessel. In preferred embodiments 
30 catheter will of course depend on the particular blood vessel 
selected for stretching, as well as on the diameter and 
number of the anchor wires and stretching wires to be used. 
The stretching wire 14a has proximal end portion 20a and 
distal end portion 22a, and the anchor wire 14b has proximal 
35 end portion 20b and distal end portion 22b. Both the 
stretching wire and the anchor wire must be able to be 
secured to the interior surface of the blood vessel to be 
stretched. FIGS. 2Aand 2B illustrate a wire 14 that can serve of the intravascular distention device and method, the axial 
forces for stretching the blood vessel are applied to at least 
one element of two or more elements, or portions thereof, 40 
that are secured (i.e., anchored) to the interior surface of the 
blood vessel to be stretched. These elements constitute the 
intravascular stretching mechanism, and preferably can be 
delivered into the blood vessel by a catheter for installation 
and use. 
as the anchor wire, the stretching wire, or both. Wire 14 has 
a proximal end portion 20 and a distal end portion 22. Distal 
end portion 22 must be changeable from a straight configu-
ration (FIG. 2A) into a second configuration that will 
frictionally engage the interior surface of the blood vessel. 
In a preferred embodiment, the second configuration is a 
45 spiral, as shown in FIG. 2B. As used herein, the term "spiral" 
includes any helical, spiral, coiled, cylindrical, or curled 
shape. 
The securing preferably is by frictional engagement, 
rather than with the use of other possible securing means 
such as adhesives or sutures. This engagement can be 
implemented with shape-changing materials, as detailed 
below, or with non-shape changing materials, which for 
example, may require balloon dilation to cause at least a 
portion of the stretching mechanism to expand and engage 
the interior lumen portion of the blood vessel. As the secured 
elements are displaced from one another, the blood vessel 
segment therebetween experiences axial stretching forces. 
In a first preferred embodiment, the intravascular stretch-
ing mechanism includes a pair of wires, the end portions of 
which can be anchored within the blood vessel, and a means 
to displace the wires away from each other and stretch the 
vessel. The blood vessel can be displaced (i.e., stretched) in 
rectilinearly, curvilinearly, or in a combination thereof. This 
displacement can be accomplished by any of a variety of 
techniques, for example, by mechanical, electromechanical, 
or hydraulic means. 
The stretching wire 14a should be of a suitable gauge and 
material of construction so that it is resistant to buckling 
50 when subjected to the pushing (stretching) forces. This 
gauge and construction can be different from that of the 
anchor wire 14b, which undergoes a pulling, rather than 
pushing, force during vessel stretching. 
In other embodiments, the stretching wire and/or anchor 
55 wire deploy into other, more complex configurations. For 
example, the stretching wire can deploy (e.g., upon warming 
to body temperature) into an anchoring spiral with a com-
pression spring, as showing in FIGS. 4A-B. FIG. 4A shows 
a stretching wire 40, having proximal end 41 and distal end 
60 42, in its straight configuration, for example, at a tempera-
ture less than body temperature. FIG. 4B shows the stretch-
ing wire 40 with the distal end portion 42 transformed into 
a compression spring 44 portion and spiral anchor portion 
46. 
In a second preferred embodiment, the intravascular 65 
stretching mechanism comprises a pair of stents connected 
The wires can be fabricated using suitable materials and 
methods to accomplish the transformation of shape shown. 
by a compression spring, which operates as a means to For example, the wires can be maintained in a straight 
US 7,300,455 B2 
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profile with a removable sleeve that snugly fits around the 
wire. Such a sleeve could simply be slid off the wire 
following insertion. The sleeve could be a separate compo-
nent that fits within the catheter lumen or the catheter itself 
could serve the sleeve function. The shape change of the 
wire could be due to a spring action inherent in the material 
of construction of the wire, such that, upon sleeve removal 
the wire changes into the curled configuration. Such a 
transformation can occur because of the elastic restorative 
forces normally exhibited in most metals and polymeric 
materials, forces that could be made, by one skilled in the 
art, to straighten a curved wire formed from these materials. 
In a preferred embodiment, this configuration-changing 
function is accomplished by having the wire, or at least the 
distal end portion thereof, include a suitable shape memory 
material. Shape memory materials typically have two dis-
tinct shapes, and the transition between these shapes can 
occur in response to various stimuli. A preferred transition 
stimulus is a change in temperature. For example, distal end 
22 of wire 14 can designed to be straight at room tempera-
ture, e.g., about 20° C., (FIG. 2A) and to form a spiral shape 
when warmed to human body temperature, e.g., about 37° 
C., or above (FIG. 2B). Other transition temperatures can be 
utilized. 
Nickel-titanium alloys (e.g., Ninitol) that exhibit super-
elastic and shape-memory effects are particularly suitable. 
Other shape memory alloys and shape memory polymeric 
materials also can be used. For example, such shape memory 
materials can be fabricated to change shape from straight to 
spiral as the wires warm to body temperature following in 
vivo insertion. Examples of shape memory polymers and 
other shape memory materials are described, for example, in 
PCT WO 99/42528 to MIT; U.S. Pat. No. 6,160,084 to 
Langer et al.; and Shape Memory Materials, (Otsuka & 
Wayman, eds.), Cambridge University Press (October 
1999), which are hereby incorporated by reference. Methods 
for forming or coating wires with such materials are known 
to those skilled in the art. 
In a preferred embodiment, the device is formed of a 
biodegradable shape memory polymer, such as described in 
U.S. Pat. No. 6,160,084 to Langeret al. The specific polymer 
could be tailored to degrade following completion of the 
stretching procedure. A device formed of such materials 
preferably would not need to be removed before vessel 
excision or grafting. 
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the distal end of the stretching wire away from the distal end 
of the anchor wire. The operating means preferably is 
operably connected to the proximal end of at least the 
stretching wire. 
A rotary motor could also be used to generate the required 
linear motion, using techniques known in the art. Alterna-
tively, the prime mover can operate hydraulically. An active 
device generally requires input over time. The prime mover 
also can be a passive device such as a spring or a combi-
10 nation of a spring and a damper, where stored mechanical 
energy is used to push and/or pull the anchored portions of 
the wires away from each other. 
Linear or rotary piezo micro-motor devices (actuators) 
deliver small step sizes, small forces, have relatively simple 
15 control electronics and inherent force overload protection. 
Suitable devices are available from a number of vendors, 
including Micro Pulse Systems, Inc. Parameters of the 
operating means include the force applied by the stretching 
mechanism, the rate and direction of movement of the 
20 stretching mechanism, the length of time that the stretching 
mechanism is operated, and the type of stretching applied 
(e.g., continuous, cyclical, or intermittent). 
The controller controls the operating means. The control-
ler can include a microprocessor that can be activated and 
25 programmed to control the stretching process. It preferably 
can be reprogranimed as needed to control the stretching 
process, based, for example, on x-ray data or other indica-
tions of how the process is proceeding. 
The mechanical or hydraulic stretching mechanism works 
30 to move the wires apart slowly over a period of up to several 
weeks. In one embodiment, the passive driver element may 
be used to provide a pre-determined stretch over time. In 
another embodiment, the driver may be progranimed to 
operate autonomously, for example to provide a stretch of 
35 several centimeters over about one month. Alternatively, 
cyclic stretching of increasing peak and mean amplitude 
may be used. Using piezo actuators, activating the driver can 
produce incremental movements of the mechanical or 
hydraulic stretching mechanism as small as a few microns. 
40 The prime mover is designed to be force limited to preclude 
overstretching the vessel. Force limitation is inherent if the 
piezoelectric actuators are used in either embodiment and, in 
the case of permanent magnetic motors, can be designed into 
the electronic driver circuit. 
45 Methods of Use 
It is important to note that the "memory" of the shape 
memory material of the compression spring is not limited to 
axial recovery. The shape memory material can take the 
form of complex curves (e.g., S-shaped) during their expan-
sion and recovery, thereby creating tortuous paths for the 50 
axial blood vessel growth and reducing axial differentiation 
between the anchoring elements while increasing the arterial 
path between them. See, e.g., FIG. 8. 
The catheter can be inserted using well-established tech-
niques for catheter insertion. Briefly, a guide wire is inserted 
using an insertion catheter and is steered to the target blood 
vessel, usually by using fluoroscopic techniques. The cath-
eter then slides over the guide wire so that its distal end is 
located in the lumen of the target blood vessel. Insertion of 
the catheter is facilitated by its radio-opaque nature. 
In the methods employing shape memory materials that 
can be activated by a temperature change, the anchor wire 
and stretching wire typically will need to be maintained at a 
temperature below body temperature until their distal ends 
are correctly positioned inside the target blood vessel lumen. 
Techniques for accomplishing this temperature control are 
well known to those skilled in the art. For example, chilled 
saline can be flowed through one or more of the catheter 
lumens to maintain the temperature of the wire that is inside 
a catheter lumen below the activation temperature. 
Operating Means and Controller 
The linear movement of the wires can be driven by a wide 55 
variety of forces and driver means known in the art. The 
movement also may be conducted using mechanical, elec-
tromechanical, hydraulic, or other means known for con-
trollably pushing/pulling one structure relative to a second 
structure. Some of these are described in, or can be adapted 60 
from those describe in, U.S. Pat. No. 6,322,553 to Vito, 
which is hereby incorporated by reference. 
The device includes means to operate the stretching 
mechanism, preferably including a prime mover and elec-
tronic drivers for the prime mover. The prime mover can be 65 
an electromechanical (active) device, such as a linear motor 
that operates the stretching mechanism to push and/or pull 
The device described with reference to FIGS. 1and2 can 
be installed and operated as illustrated in FIGS. 3A-E. In 
these FIGS., blood flow should be from left (proximal) to 
right (distal). FIG. 3A shows a catheter 12 in an inserted 
position within target blood vessel 30, such that distal end 18 
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of catheter 12 is in the desired position for deployment of the 
stretching wire. As stretching wire 14a is deployed, its distal 
end portion 22a warms to body temperature and changes to 
a spiral, expanded configuration and engages circumferen-
tially the interior surface 31 of blood vessel 30, as shown in 
FIG. 3B. This engagement causes the stretching wire 14a to 
be secured to the blood vessel 30 and establishes a distal 
anchoring point therein. 
10 
30 as shown in FIG. SE. It may be convenient in this 
embodiment to simply leave the catheter in place while 
stretching occurs. 
B. Design Utilizing Combination of Stents and Springs 
In another embodiment, the intravascular stretching 
means comprises a pair of stents, wherein the stents, rather 
than the wire spirals described above, function as the 
anchoring elements. While a variety of stent designs are 
commercially available or otherwise known for use in Next, a proximal anchoring point is established. As shown 
in FIG. 3C, the catheter is first moved proximally (to the left) 
such that distal end 18 of catheter 12 is in the desired 
position for deployment of the anchor wire. As anchor wire 
l4b is deployed, its distal end portion 22b warms to body 
temperature and changes to a spiral, expanded configuration 
and engages circumferentially the interior surface 32 of 
blood vessel 30, as shown in FIG. 3D. This engagement 
causes the anchor wire 14b to be secured to the blood vessel 
30 and establishes a proximal anchoring point therein. These 
distal and proximal anchoring points, at surfaces 31 and 32, 
respectively, establish the blood vessel segment to be 
stretched. 
10 maintaining blood vessel diameter, the stents of the present 
methods and devices are designed and used to impart axial 
forces to increase the length of the vessel. 
The Device and Components Thereof 
One example of such a design is illustrated in FIGS. 
15 6A-B. FIGS. 6A and 6B show intravascular device 60, 
which is comprised of a proximal stent 62, a distal stent 64, 
and a compression spring 66 secured between the distal and 
proximal stents. One end of the proximal stent 62 is con-
nected to, or integral with, the proximal end 68a of com-
Stretching forces are then applied to one or both of the 
wires 14a and 14b. Production and control of these stretch-
20 pression spring 66, and one end of the distal stent 64 is 
connected to, or integral with, the distal end 68b of com-
pression spring 66. FIG. 6A shows device 60 with spring 66 
in its compressed configuration, and FIG. 6B shows device 
ing forces can be provided as described above. Stretching 
can be continuous, cyclical, or intermittent, or in a combi- 25 
nation thereof. FIG. 3E illustrates that the stretching wire 
l4a has been pushed and caused the blood vessel 30 to be 
stretched and grown between points 31 and 32. While the 
stretching shown in FIG. 3E is linear (or rectilinear), stretch-
ing also can occur in curvilinear manner or in a combination 30 
of rectilinear and curvilinear stretching. 
The device described with reference to FIGS. 1 and 3 can 
be installed and operated as illustrated in FIGS. SA-E. In 
these FIGS., blood flow should be from left (proximal) to 
right (distal). FIG. SA shows a catheter 12 in an inserted 35 
position within target blood vessel 30, such that distal end 18 
of catheter 12 is in the desired position for deployment of the 
stretching wire. As stretching wire 40 is partially deployed, 
the tip end portion of distal end portion 42 warms to body 
temperature and changes to a spiral, expanded configuration, 40 
forming a spiral 46 which engages circumferentially the 
interior surface 31 of blood vessel 30, as shown in FIG. SB. 
This engagement causes the stretching wire 14a to be 
secured to the blood vessel 30 and establishes a distal 
anchoring point therein. 45 
As stretching wire 40 continues to be deployed, an 
intermediary portion of the distal end portion 42 transforms 
into a helical configuration operable as a compression spring 
44, as shown in FIG. SC. This compression spring 44 has an 
outer diameter that is smaller than that of the spiral 46, so 50 
that the compression spring 44 does not frictionally engage 
and become anchored to the blood vessel wall. 
60 with spring 66 in its expanded, or stretched, configura-
tion. 
Essentially any stent suitable for vascular implantation 
can be adapted for use in the present intravascular device. 
The stent preferably is self-expanding, but also can deploy-
able by other means (e.g., balloon dilation). The stent can be 
of various types, including but not limited to coil, mesh, and 
porous structures. One example of an expandable stent is 
described in U.S. Pat. No. 6,033,436 to Steinke, et al. FIG. 
7 shows one embodiment of a proximal or distal stent 70, 
which is integral with compression spring 72 (only partially 
shown). This anchoring stent 70 is the structural feature that 
positively engages the vessel wall (not shown). Numerous 
other designs are known in the art or can be routinely 
adapted therefrom. Some configurations are described in 
U.S. Pat. No. 6,193,744 to Ehr et al. These patents are 
hereby incorporated by reference. 
Preferably, each stent is between about 5 and 20 mm, 
more preferably about 10 mm, in length. The diameter of the 
stent desirably is selected for the particular donor vessel, the 
size of which can vary. 
The compression spring can be integrally formed with the 
stents, or the compression spring can be welded or otherwise 
attached to the stents following fabrication of each compo-
nent. Preferably, the entire device is fabricated in one piece, 
i.e., as a single, contiguous assembly. 
The device should be formed of and/or coated with a 
biocompatible material, as known in the art. Preferably, the 
compression spring is made of or includes a shape memory 
material, as describe herein (e.g., nickel-titanium alloys and 
shape memory polymers). The compression spring can alter-
55 natively be made from non-shape memory materials (e.g., 
titanium, stainless steel, or a biocompatible polymer). The 
stents preferably are also fabricated from a shape memory 
material, but may be made from a non-shape memory 
After the compression spring 44 is fully formed, a proxi-
mal anchoring point is established. As shown in FIG. SD, the 
catheter is first moved proximally (to the left) such that distal 
end 18 of catheter 12 is in the desired position for deploy-
ment of the anchor wire. As anchor wire SO is deployed, its 
distal end portion S2 warms to body temperature and 
changes to a spiral, expanded configuration and engages 
circumferentially the interior surface 32 of blood vessel 30, 60 
as shown in FIG. 3D. This engagement causes the anchor 
wire SO to be secured to the blood vessel 30 and establishes 
a proximal anchoring point therein. 
These distal and proximal anchoring points, at surfaces 31 
and 32, respectively, establish the blood vessel segment to be 
stretched. Stretching forces are then applied by the release of 
compression in spring 44, which stretches the blood vessel 
material, as describe herein. 
Methods of Use 
The intravascular device is inserted into the target (i.e., 
donor) blood vessel. Then, the stents are self-expanded (e.g., 
if they comprise a shape memory material) or are expanded 
with the use of an installation device, such as a balloon, 
65 using or adapting techniques known in the art. The expan-
sion process causes each stent to become frictionally 
engaged, and thus anchored, to a circumferential portion of 
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the interior surface of the blood vessel. The stents are 
anchored in positions such that the spring therebetween is in 
compression. The spring thus exerts an axial, expansion 
force causing the section of blood vessel between the anchor 
points to be stretched. The expansion of the compression 
spring thus causes the length of that blood vessel section to 
lengthen. 
FIGS. SA-B illustrate one embodiment of a stent-type 
stretching device SO comprising stents S4 and S6 with 
compression spring S2 in a compressed configuration (FIG. 10 
SA) and with the compression spring S2 in an expanded or 
stretched configuration (FIG. SB). FIG. SB illustrates how a 
blood vessel could be stretched in a curvilinear manner to 
twice the original length, L. A stent-type device also could 
expand to stretch in a linear (or rectilinear) manner or in 15 
combination of curvilinear and rectilinear motion. 
C. Other Design Features 
The methods and devices described herein optionally can 
include growth factors or other growth stimulating agents 
(e.g., hormones) to further enhance blood vessel growth. For 20 
example, such growth stimulating agents can be delivered to 
the blood vessel by impregnating the materials forming the 
wires, stents or other device components. Alternatively or 
additionally, the device components can be provided with a 
suitable coating or reservoirs that can contain and control- 25 
!ably release such agents during the extension process. 
Examples of growth factors include vascular endothelial 
growth factor (VEGF), endothelial cell growth factor 
(ECGF), basic fibroblast growth factor (bFGF), and platelet 
derived growth factor (PDGF). Biocompatible polymeric 30 
materials for controlled release that are known in the art for 
drug delivery (see e.g., U.S. Pat. No. 5,879,713 to Roth et 
al.) can be adapted for use with the devices described herein. 
The devices and methods also can be used in combination 
with external electric, magnetic, or electromagnetic fields 35 
applied as a growth stimulus. See e.g., U.S. Pat. No. 4,846, 
181 to Miller. 
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be rejected by humans. For example, a distended artery from 
a transgenic pig might be used to provide a xenogeneic 
arterial graft in a human. 
The devices and methods can be sized to stretch blood 
vessels (e.g., veins, arteries) of essentially any size and 
located in or excised from a variety of sites in the body of 
the patient or donor or animal. Preferred blood vessels 
include, but are not limited to, the internal mammary arter-
ies, the gastroepipolic artery, the gastric artery, the radial 
artery, the femoral artery, and the splenic artery. Other 
arteries and veins may also be suitable blood vessels for use 
with the methods and devices. 
In a preferred embodiment of the in vivo distension 
method, the stretching mechanism is inserted into a donor 
blood vessel, for example using a catheter, and vessel 
distension effected over a period of time. Then the stretching 
mechanism is withdrawn, and a portion of the donor blood 
vessel section is surgically removed. The ends of the donor 
vessel can then be sutured end to end to repair the donor 
vessel, as is commonly done in vascular repair without 
complication. Some blood vessels used for coronary bypass 
surgery, such as the gastroepipolic and radial arteries, can be 
removed with minimal morbidity such that repair is unnec-
essary. The removed blood vessel section is then ready for 
use as a graft in a patient in need thereof, who preferably is 
the same patient supplying the donor vessel. 
Grafts for coronary by-pass surgery are typically between 
about 10 cm and 15 cm in length, whereas grafts for by-pass 
in the peripheral circulation are typically about 25 cm or 
more in length. Those of skill in the art can readily optimize 
the rate of vessel distension. Distension rates can be linear 
or nonlinear, and may average, for example, between about 
5 and 10 mm/day. 
The device can also be used for in vitro distension. 
Currently, a short segment of blood vessel can be salvaged 
during conventional bypass surgery and an in vitro organ 
culture or bioreactor system can be used to grow sufficient The devices also can optionally include appropriate drugs (e.g., therapeutic or prophylactic agents) impregnated into or 
coated to structural components, for example to minimize 
infections, thrombosis, inflammatory reactions, scar tissue 
formation, adhesion formation, and/or other adverse tissue 
reactions. For example, where tissue growth is to be 
avoided, certain antifibrotic agents may be present, such as 
5-fluourouracil or mitomycin. The device may be more 
generally provided with coatings that are antibiotic or anti-
40 graft tissue for a second surgery. Such surgeries represent 
about 30% of all bypass operations. The methods and 
devices described herein can be adapted to work with such 
surgeries, to increase the length of graft material and/or to 
reduce the required length of the salvaged segment. 
inflammatory. 
The intravascular stretching device also can be designed 
to limit adhesion formation while installed in the blood 
vessel. For example, the wires, stents, compression springs, 
or other components can be impregnated or coated with 
materials selected to reduce adhesion formation as known in 
the art. Examples of such coating materials include, but are 
not limited to, parylene, polytetrafluoroethylene (e.g., 
TEFLON™) and chromium (e.g., ME-92™, Armoloy 
Corp.), which can be used to coat a variety of other metal 
and polymer substrates. 
Application of the Distension Devices and Methods 
The present devices and methods are useful for forming a 
vascular graft by axially stretching (i.e., distending or 
extending) a donor blood vessel to stimulate growth. This 
stretching can performed in vivo or in vitro. 
45 Stretched blood vessels can be effectively preserved for 
bypass surgery, for example, using known cryogenic or 
freeze-drying techniques. 
In this method, a portion of a donor blood vessel (e.g., 
shorter than that needed for a graft) is surgically excised 
50 from the patient in need of the graft, and then the vessel 
portion is stretched over a period of time in vitro in a 
medium for cell growth, for example, as in a bioreactor. As 
used herein, the phrase "medium for cell growth" includes 
any in vitro system for facilitating cell division, extra-
55 cellular matrix formation, and growth of vessel tissue. See, 
for example, U.S. Pat. No. 5,899,936 to Goldstein; U.S. Pat. 
No. 5,879,875, to Wiggins, et al.; and U.S. Pat. No. 5,888, 
720 to Mitrani, which describe techniques for organ and 
tissue culture which can be adapted to the methods described 
60 herein. All or a portion of the distended vessel is then ready 
for use as a graft in the patient. Where the donor is the 
recipient of the graft, the result using either approach 
advantageously is a totally autologous, living vascular graft. 
While an autologous graft is preferred, the devices and 
methods described herein also can be applied to an artery 65 
from another human or other animal, including transgenic 
animals genetically engineered to have tissues that will not 
Modifications and variations of the present invention will 
be obvious to those of skill in the art from the foregoing 
detailed description. Such modifications and variations are 
intended to come within the scope of the following claims. 
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We claim: 
1. An implantable medical device for distending a blood 
vessel to induce axial growth of the blood vessel compris-
ing: 
an intravascular stretching mechanism securable to an 
interior luminal surface of a blood vessel in vivo; and 
a means for operating the intravascular stretching mecha-
nism in vivo to cause the vessel to stretch and grow 
axially; 
wherein the intravascular stretching mechanism com- 10 
prises: 
an anchoring wire having a distal end portion; and 
a stretching wire having a distal end portion; 
wherein the distal end portions are separately anchorable 
to the luminal surface at positions axially remote from 15 
one another. 
14 
10. The implantable medical device of claim 1, wherein 
the means for operating the stretching mechanism compris-
ing a controller. 
11. An implantable medical device for distending a blood 
vessel to induce axial growth of the blood vessel compris-
ing: 
an intravascular stretching mechanism securable to an 
interior luminal surface of a blood vessel in vivo; and 
a means for operating the intravascular stretching mecha-
nism in vivo to cause the vessel to stretch and grow 
axially; 
wherein the intravascular stretching mechanism com-
prises a first stent, a second stent, and a compression 
spring operably connected to the first stent and the 
second stent, the first and second stents being sepa-
rately anchorable to the interior luminal surface of the 
blood vessel at positions axially remote from one 
another. 
2. The implantable medical device of claim 1, wherein the 
distal end portion of the anchoring wire, the distal end 
portion of the stretching wire, or both, comprise a shape 
memory material. 20 12. The implantable medical device of claim 11, wherein 
the first stent, the second stent, the compression spring, or a 
combination thereof, comprises a shape memory material. 
13. The implantable medical device of claim 12, wherein 
the shape memory material comprises a shape memory alloy 
or a shape memory polymer. 
3. The implantable medical device of claim 2, wherein the 
shape memory material comprises a shape memory alloy or 
a shape memory polymer. 
4. The implantable medical device of claim 2, wherein in 
response to a change in temperature effective to trigger a 25 
change in the shape memory material, the distal end portion 
of the stretching wire changes, the distal end portion of the 
anchoring wire, or both distal end portions, change, from a 
substantially straight form into a spiral configuration for 
securing engagement with the interior luminal surface of the 30 
blood vessel. 
5. The implantable medical device of claim 4, wherein in 
response to a change in temperature effective to trigger a 
change in the shape memory material, an intermediary 
portion of the stretching wire changes from a substantially 35 
straight form into a helical configuration operable as a 
compression spring. 
6. The implantable medical device of claim 1, further 
comprising a catheter having at least two lumens extending 
between a proximal end and a distal end, one of said at least 40 
two lumens being suitable for delivering the stretching wire 
into the blood vessel lumen, and another of said at least two 
catheter lumens being suitable for delivering the anchor wire 
into the blood vessel lumen. 
7. The implantable medical device of claim 1, wherein the 45 
means for operating comprises a prime mover that is 
mechanically, electromechanically, or hydraulically driven. 
8. The implantable medical device of claim 1, wherein the 
means for operating the stretching mechanism is capable of 
causing an axial stretching force to be continuously applied 50 
to the blood vessel. 
9. The implantable medical device of claim 1, wherein the 
means for operating the stretching mechanism is capable of 
causing an axial stretching force to be intermittently applied 
to the blood vessel. 
14. The implantable medical device of claim 1, further 
comprising at least one therapeutic or prophylactic agent for 
release in vivo. 
15. The implantable medical device of claim 14, wherein 
the therapeutic or prophylactic agent comprises a growth 
stimulating agent. 
16. The implantable medical device of claim 1, wherein 
all or a portion of the intravascular stretching mechanism is 
radio-opaque. 
17. A device for distending a blood vessel in vivo to 
induce axial growth of the blood vessel comprising: 
an intravascular stretching mechanism which comprises 
an anchoring wire having a distal end portion, and 
a stretching wire having a distal end portion, 
wherein the distal end portions are separately anchorable 
to a luminal surface of a blood vessel in vivo at 
positions axially remote from one another; and 
a prime mover for operating the intravascular stretching 
mechanism to cause the vessel to stretch in vivo and 
grow axially. 
18. The device of claim 17, wherein the prime mover 
comprises an electro-mechanical device adapted to push 
and/or to pull the distal end of the stretching wire away from 
the distal end of the anchor wire. 
19. The device of claim 17, wherein the prime mover 
comprises at least one spring or a combination of a spring 
and a damper. 
* * * * * 
